Dolby Laboratories (DLB) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DLB shares.
View DLB analyst ratings or view top-rated stocks.

3 analysts have issued 1 year price objectives for Dolby Laboratories' stock. Their DLB share price forecasts range from $90.00 to $116.00. On average, they anticipate the company's share price to reach $103.00 in the next year. This suggests a possible upside of 23.5% from the stock's current price.
View analysts price targets for DLB or view top-rated stocks among Wall Street analysts.

Dolby Laboratories' stock was trading at $70.54 on January 1st, 2023. Since then, DLB shares have increased by 18.3% and is now trading at $83.43.
View the best growth stocks for 2023 here.

Dolby Laboratories saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 737,800 shares, a decrease of 16.4% from the April 15th total of 882,500 shares. Based on an average trading volume of 338,500 shares, the short-interest ratio is presently 2.2 days. Approximately 1.3% of the shares of the company are sold short.
View Dolby Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our DLB earnings forecast.

Dolby Laboratories, Inc. (NYSE:DLB) announced its quarterly earnings data on Tuesday, November, 16th. The electronics maker reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.56 by $0.02. The electronics maker had revenue of $285.03 million for the quarter, compared to analysts' expectations of $299.95 million. Dolby Laboratories had a net margin of 18.96% and a trailing twelve-month return on equity of 10.81%. The business's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.28 earnings per share.

Dolby Laboratories announced a quarterly dividend on Thursday, May 4th. Investors of record on Tuesday, May 16th will be given a dividend of $0.27 per share on Tuesday, May 23rd. This represents a $1.08 annualized dividend and a yield of 1.29%. The ex-dividend date is Monday, May 15th.
Read our dividend analysis for DLB.

ETFs with the largest weight of Dolby Laboratories (NYSE:DLB) stock in their portfolio include LeaderShares AlphaFactor Tactical Focused ETF (LSAT), ProShares S&P Technology Dividend Aristocrats ETF (TDV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Fount Metaverse ETF (MTVR), Pacer US Large Cap Cash Cows Growth Leaders ETF (COWG), WisdomTree U.S. Multifactor Fund (USMF), American Century Low Volatility ETF (LVOL) and Vanguard U.S. Minimum Volatility ETF (VFMV).

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.08 per share and currently has a dividend yield of 1.31%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 43.72%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 38.71% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

Dolby Laboratories updated its third quarter 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $0.47-$0.62 for the period, compared to the consensus earnings per share estimate of $0.71. The company issued revenue guidance of $285.00 million-$315.00 million, compared to the consensus revenue estimate of $303.92 million.

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (5.51%), BlackRock Inc. (3.25%), Clearbridge Investments LLC (2.94%), Ninety One UK Ltd (2.35%), Mackenzie Financial Corp (1.56%) and Bank of New York Mellon Corp (1.53%). Insiders that own company stock include Anjali Sud, Avadis Tevanian, Emily Rollins, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Peter C Gotcher, Ryan Nicholson, Simon Segars, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $83.43.

Dolby Laboratories (NYSE:DLB) has a market capitalization of $7.97 billion and generates $1.28 billion in revenue each year. The electronics maker earns $184.09 million in net income (profit) each year or $2.47 on an earnings per share basis.

The company employs 2,336 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for the company is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at investor@dolby.com, or via fax at 415-645-4000.